• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Immunoglobulins
    5 Drugs classified under this drug class


    All the Drug Class Drugs

    Beriglobin P
    Genmedix
    RX
    partial basket chart
    Beriglobin P

    Immunoglobulins. Human Normal Immunoglobulin 160 mg/ml.
    PFS: 1 x 2 cc, 5 cc. See lit.
    Defic. defect. antibody synth., protracted
    transitory hypogammaglobulem.,
    proph. hepatit. A, measles or attenuat.
    measles.
    C/I: Severe thrombocytopen., other
    coag. disords., isolated immunoglobulin
    A (IgA) defic.

    Intratect 100 g/l
    Kamada
    RX
    not in the basket chart
    Intratect 100 g/l

    Immunoglobulins. Human Normal Immunoglobulin 100 g/l.
    VIAL (sol. for infus.): 1x10 ml, 25 ml, 50 ml, 100 ml, 200 ml. Replacement ther. in primary immunodefic., init. dose: 0.4-0.8 g/kg, thereafter 0.2-0.8 g/kg every 3-4 wks. to obtain IgG trough level of at least 5-6 g/l.
    Replacem. ther. in second. immunodefic.: 0.2-0.4 g/kg, every 3-4 wks. to obtain IgG trough level of at least 5-6 g/l.
    Congenit. AIDS: 0.2-0.4 g/kg, every 3-4 wks.

    Hypogammaglobulinaemia (<4 g/l) in pts. after allogeneic haematopoietic stem cell transplant.: 0.2-0.4 g/kg, every 3-4 wks. to obtain IgG trough level above 5 g/l
    .
    Prim. immune thrombocytop.: 0.8-1 g/kg on day 1, possibly repeated once within 3 days, or 0.4 g/kg/d for 2-5 d.
    Guillain Barré syndr.: 0.4 g/kg/d for 5 d.
    Kawasaki dis.: 1.6-2 g/kg in divided doses over 2-5 d. in assoc. with acetylsalic. acid or 2 g/kg in one dose in assoc. with acetylsalic. acid.
    Method of admin.: initial rate of not more than 1.4 ml/kg/h for 30 min.
    If well toler., the rate of admin. may gradual. be incr. to a max. of 1.9 ml/kg/h for the remainder of the infus.
    Replacement Therapy: In pts. who have tolerated the infus. rate of 1.9 ml/kg/h well, the rate may be gradual. incr.to 6 ml/kg/h and if still tolerat. well, it may be further incr. gradual. to a max. of 8 ml/kg/h.
    In general, dosage and infus. rates have to be individ. tailor. accord.to the pt's needs.
    Replacem. ther. in adult., and child. & adolesc. (0-18 yrs.) in:
    Primary immunodefic. syndr. with impair. antibod. product.
    Hypogammaglobulinaemia and recur. bact. infec. in pts. with chron. lymphocytic leukaemia, in whom prophylact. antibiotics have failed.
    Hypogammaglobulinaemia and recur. bact. infec. in plateau phase multiple myeloma pts. who have failed to respond to pneumococcal immunisat.
    Hypogammaglobulinaemia in pts. after allogen. haematop. stem cell transplant. (HSCT).
    Congen. AIDS with recur. bact. infec.
    Immunomodulat. in adul., and child. and adolesc. (0-18 yrs.) in:
    Prim. immune thrombocytop. (ITP), in pts. at high risk of bleed. or prior to surg. to correct the platelet count.
    Guillain Barré syndr.
    Kawasaki dis.
    C/I: Hypersens. Pts. with selective IgA defic. who develop. antibod. to IgA, as admin. an IgA-contain. product can result in anaphylax.

    Intratect 50 g/l
    Kamada
    RX
    partial basket chart
    Intratect 50 g/l

    Immunoglobulins. Human Normal Immunoglobulin 50 mg/ml.
    VIAL (sol.for infus.): 20, 50, 100, 200 ml. Method of admin. for all indic. Should be infus. IV at an init. rate of not more than 1.4 ml/kg/h for 30 min. If well tolerated. the rate of admin. may gradually be incr. to a max. of 1.9 ml/kg/h for the remainder of the infus.
    Replacement ther. in primary immunodefic., init. dose: 0.4-0.8 g/kg, thereafter 0.2-0.8 g/kg every 3-4 wks. to obtain IgG trough level of at least 5-6 g/l.
    Replacem. ther. in second. immunodefic.: 0.2-0.4 g/kg, every 3-4 wks. to obtain IgG trough level of at least 5-6 g/l. Congenit. AIDS: 0.2-0.4 g/kg, every 3-4 wks.
    Hypogammaglobulinaemia (< 4 g/l) in pts. after allogeneic haematopoietic stem cell transplant.: 0.2-0.4 g/kg, every 3-4 wks. to obtain IgG trough level above 5 g/l
    .
    Prim. immune thrombocytop.: 0.8-1 g/kg on day 1, possibly repeated once within 3 days, or 0.4 g/kg/d for 2-5 d.
    Guillain Barré syndr.: 0.4 g/kg/d for 5 d.
    Kawasaki dis.: 1.6-2 g/kg in divided doses over 2-5 d. in assoc. with acetylsalic. acid or 2 g/kg in one dose in assoc. with acetylsalic. acid
    .
    Replacem. ther. in adult., and child. & adolesc. (0-18 yrs.) in:
    Primary immunodefic. syndr. with impair. antibod. product.
    Hypogammaglobulinaemia and recur. bact. infec. in pts. with chron. lymphocytic leukaemia, in whom prophylact. antibiotics have failed.
    Hypogammaglobulinaemia and recur. bact. infec. in plateau phase multiple myeloma pts. who have failed to respond to pneumococcal immunisat.
    Hypogammaglobulinaemia in pts. after allogen. haematop. stem cell transplant. (HSCT).
    Congen. AIDS with recur. bact. infec.
    Immunomodulat. in adult., and child. and adolesc.(0-18 yrs.) in:
    Prim. immune thrombocytop. (ITP), in pts. at high risk of bleed. or prior to surg. to correct the platelet count.
    Guillain Barré syndr.
    Kawasaki dis.
    C/I: Hypersens. Pts. with selective IgA defic. who develop. antibod. to IgA, as admin. an IgA-contain. product can result in anaphylax.

    Privigen
    Genmedix
    RX
    not in the basket chart
    Privigen

    Immunoglobulins. Human Normal Immunoglobulin 100 g/l.
    VIAL (sol. for I.V. infus.): 1 x 2.5 g/ml; 5
    g/50 ml; 10 g/100 ml. Depend. on
    indicat. See lit.
    Replace. ther. in prim. immunodefic.
    synds such congen.
    agammaglobulinem., hypogammaglob
    ulinem., common/severe variable
    immunodefic; Wiskott-Aldrich syndr:
    Myeloma/chronic lymphocytic leukem.
    with severe second.
    hypogammaglobulinem. and recurr.
    infects. Child with congent. AIDS and
    recurr. infects. Immunomodulat: ITP in
    child, adults at high risk of bleed./prior to
    surgical intervents. to correct platelet
    count; Guillan-Barré syndr., Kawasaki
    dis.; Allogeneic bone marrow transplant.
    C/I: Hypersens.

    Thymoglobuline
    Sanofi
    RX
    partial basket chart
    Thymoglobuline

    Immunoglobulins. Rabbit Anti-Human Thymocyte Immunoglobulin 25 mg/vial.
    VIAL (+ SOLVENT): 1 x 25 mg + 5 ml
    solv. I.V. infus. depends on the indic.,
    the admin. regimen and comb. with
    other immunosuppr. agents. See lit.
    Prev. and tmt. of graft reject., tmt of acute
    GvHD, hematol. tmt of aplastic anem.
    C/I: Act. acute or chron. infec. which
    would contraind. addition. immunosupp.
    Hypersens. to rabbit proteins or any of
    the excip.

    CLOSE